Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

PHASE2RecruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

March 12, 2022

Primary Completion Date

October 15, 2026

Study Completion Date

October 15, 2031

Conditions
B-cell Acute Lymphoblastic LeukemiaObesity
Interventions
BEHAVIORAL

IDEAL2 Intervention

Intervention of diet and exercise to improve outcomes for ALL patients

Trial Locations (20)

10032

NOT_YET_RECRUITING

Columbia University Medical Center, New York

19104

RECRUITING

Children's Hospital of Philadelphia, Philadelphia

21231

NOT_YET_RECRUITING

Johns Hopkins / Sydney Kimmel Cancer Center, Baltimore

28203

RECRUITING

Levine Children's Hospital, Charlotte

30322

NOT_YET_RECRUITING

Children's Healthcare of Atlanta at Egleston, Atlanta

43205

NOT_YET_RECRUITING

Nationwide Children's Hospital, Columbus

45229

NOT_YET_RECRUITING

Cincinnati Children's Hospital Medical Center, Cincinnati

48109

RECRUITING

C.S. Mott University of Michigan, Ann Arbor

53226

NOT_YET_RECRUITING

Children's Hospital of Wisconsin, Milwaukee

55404

RECRUITING

Children's Hospitals and Clinics of Minnesota, Minneapolis

60611

RECRUITING

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

75235

RECRUITING

University of Texas, Southwestern, Dallas

76104

NOT_YET_RECRUITING

Cook Children's Medical Center, Fort Worth

77030

RECRUITING

Baylor Texas Children's Hospital, Houston

80045

RECRUITING

Colorado Children's Hospital, Denver

84113

RECRUITING

Primary Children's Hospital, Salt Lake City

90027

RECRUITING

Children's Hospital Los Angeles, Los Angeles

92868

RECRUITING

Children's Hospital Orange County, Orange

94158

RECRUITING

UCSF School of Medicine, San Francisco

97239

NOT_YET_RECRUITING

Oregon Health & Science University, Portland

All Listed Sponsors
collaborator

Therapeutic Advances in Childhood Leukemia Consortium

OTHER

lead

Etan Orgel

OTHER